Note that some links may require registration or subscription.
Totally Cool is recalling multiple brands of ice cream products because they have the potential to be contaminated with Listeria monocytogenes.
With COVID cases growing or most likely growing in 39 states according to the CDC, a summer wave may be here.
Novo Nordisk is planning to build a $4.1 billion facility in North Carolina as demand for weight-loss drugs continues to grow. (The Hill)
Teva Pharmaceuticals announced the launch of the first authorized GLP-1 generic of liraglutide injection (Victoza) in the U.S.
Surgeon General Vivek Murthy, MD, MBA, declared gun violence a public health crisis, noting it’s created a cycle of trauma and fear that is damaging Americans’ mental health.
HHS finalized a rule establishing disincentives for healthcare providers that commit information blocking.
Hospital-onset bacteremia events in the neonatal intensive care unit were associated with increased mortality, a retrospective multicenter cohort study showed. (JAMA Pediatrics)
The National Transportation Safety Board will hold another hearing to discuss the cause of a 2023 fiery Ohio freight train wreck. (AP)
Social Security updated a list of jobs that have been used to deny disability benefits.
Paris is promoting an Olympic Village without air conditioning, but Team USA and others aren’t chill with the concept. (NPR)
In some states, masks are moving from being mandated to being criminalized. (Washington Post)
Harmony Biosciences said the FDA approved pitolisant (Wakix) tablets to treat excessive daytime sleepiness in pediatric patients with narcolepsy ages 6 years and older.
The FDA converted the pulmonary tuberculosis drug bedaquiline (Sirturo) to traditional approval based on the drug’s confirmatory trial.
Here’s a closer look at state lawmakers’ efforts to bring down healthcare costs. (Washington Post)
The U.S. Supreme Court rejected COVID vaccine appeals from a nonprofit founded by Robert F. Kennedy Jr. (AP)
Therapists are learning how to help farmers deal with stress. (KFF Health News)
A U.K. boy with severe epilepsy became the first patient in the world to trial a new neurostimulator fitted in the skull to control seizures. (BBC)
Source link : https://www.medpagetoday.com/publichealthpolicy/productalert/110802
Author :
Publish date : 2024-06-25 13:40:40
Copyright for syndicated content belongs to the linked Source.